[1]
“THE USE OF INTERMEDIARIES IN THE PERFORMANCE OF SALES ACTIVITIES BY PHARMACEUTICAL ENTERPRISES”, IE, no. 1, pp. 131–136, May 2023, doi: 10.37332/2309-1533.2023.1.18.